Company intelligence / Profile preview
Sebela Pharmaceuticals
- Ownership
- Private
- Employees
- ~206
- Development stage
- Phase 3
Overview
Sebela Pharmaceuticals is a U.S.-based company with a strong focus on Gastroenterology and Women's Health. It has developed and commercialized several products, including SUFLAVE, SUTAB, and SUPREP BOWEL PREP KIT for gastrointestinal applications, and MIUDELLA, a hormone-free IUD for contraception.
- Therapeutic areas
- GastroenterologyWomen's Health
- Modalities
- Small moleculesintrauterine devices (IUDs)
- Industry
- Biotech
Drug pipeline
25 assets24 more assets in the full pipeline.
Beyond the preview
Go deeper on Sebela Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sebela Pharmaceuticals.